Resveratrol Sensitizes Selectively Thyroid Cancer Cell to 131-Iodine Toxicity

Journal of Toxicology

Volumn 2014, Issue , 2014, Pages

  Hosseinimehr, Seyed Jalal ^a   Hosseini, Seyed Amir Hossein ^a  

^a MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IODINE 131; RESVERATROL;

ARTICLE; CANCER CELL LINE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG POTENTIATION; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MTT ASSAY; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; THYROID CANCER;

EID: 84921330714     PISSN: 16878191     EISSN: 16878205     Source Type: Journal    
DOI: 10.1155/2014/839597     Document Type: Article

References (42)

1. R. J. Robbins and M. J. Schlumberger, "The evolving role of 131I for the treatment of diferentiated thyroid carcinoma, " Journal of Nuclear Medicine, vol. 46, supplement 1, pp. 28S-37S, 2005.
2. S. J. Hosseinimehr, "Flavonoids and genomic instability induced by ionizing radiation, " Drug Discovery Today, vol. 15, no. 21-22, pp. 907-918, 2010.
3. Z. Noaparast and S. J. Hosseinimehr, "Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy, " Future Oncology, vol. 9, no. 8, pp. 1145-1159, 2013.
4. J. B. Little, "Radiation carcinogenesis, " Carcinogenesis, vol. 21, no. 3, pp. 397-404, 2000.
5. S. J. Hosseinimehr, "Potential utility of radioprotective agents in the practice of nuclear medicine, " Cancer Biotherapy and Radiopharmaceuticals, vol. 24, no. 6, pp. 723-731, 2009.
6. K. H. Bohuslavizki, W. Brenner, S. Lassmann et al., "Quantitative salivary gland scintigraphy-a recommended examination prior to and afer radioiodine therapy, " NuklearMedizin, vol. 36, no. 3, pp. 103-109, 1997.
7. S. M. Chow, "Side effects of high-dose radioactive iodine for ablation or treatment of diferentiated thyroid carcinoma, " Journal of the Hong Kong College of Radiologists, vol. 8, no. 3, pp. 127-135, 2005.
8. D. van Nostrand, J. Neutze, and F. Atkins, "Side effects of "rational dose" iodine-131 therapy for metastatic well-diferentiated thyroid carcinoma, " Journal of Nuclear Medicine, vol. 27, no. 10, pp. 1519-1527, 1986.
9. A. M. Samuel, T. P. Unnikrishnan, N. S. Baghel, and B. Rajashekharrao, "Effect of radioiodine therapy on pulmonary alveolar-capillary membrane integrity, " Journal of Nuclear Medicine, vol. 36, no. 5, pp. 783-787, 1995.
10. M. A. Walter, C. P. Turtschi, C. Schindler, P. Minnig, J. Müller-Brand, and B. Müller, "The dental safety profle of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study, " Journal of Nuclear Medicine, vol. 48, no. 10, pp. 1620-1625, 2007.
11. K. Nakada, T. Ishibashi, T. Takei et al., "Does lemon candy decrease salivary gland damage afer radioiodine therapy for thyroid cancer?" Journal of Nuclear Medicine, vol. 46, no. 2, pp. 261-266, 2005.
12. M. Ballardin, F. Gemignani, L. Bodei et al., "Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131, " Mutation Research, vol. 514, no. 1-2, pp. 77-85, 2002.
13. S. Gutiérrez, E. Carbonell, P. Galofré, A. Creus, and R. Marcos, "Cytogenetic damage afer 131-iodine treatment for hyperthy-roidism and thyroid cancer: a study using the micronucleus test, " European Journal of Nuclear Medicine, vol. 26, no. 12, pp. 1589-1596, 1999.
14. 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes, " Journal of Nuclear Medicine, vol. 45, no. 4, pp. 608-611, 2004.
15. A. Csiszar, "Anti-infammatory effects of resveratrol: Possible role in prevention of age-related cardiovascular disease, " Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 117-122, 2011.
16. T. Szekeres, P. Saiko, M. Fritzer-Szekeres, B. Djavan, and W. Jäger, "Chemopreventive effects of resveratrol and resveratrol derivatives, " Annals of the New York Academy of Sciences, vol. 1215, no. 1, pp. 89-95, 2011.
17. A. F. Ferńandez and M. F. Fraga, "The effects of the dietary polyphenol resveratrol on human healthy aging and lifespan, " Epigenetics, vol. 6, no. 7, pp. 870-874, 2011.
18. H.-L. Zhu, "Resveratrol and its analogues: promising antitumor agents, " Anti-Cancer Agents in Medicinal Chemistry, vol. 11, no. 5, pp. 479-490, 2011.
19. S. H. Kim, J. H. Park, Y. J. Kim, and K. H. Park, "The neuroprotective effect of resveratrol on retinal ganglion cells afer optic nerve transection, " Molecular Vision, vol. 19, pp. 1667-1676, 2013.
20. X.-P. Shi, S. Miao, Y. Wu et al., "Resveratrol sensitizes tamoxifen in antiestrogen-resistant breast cancer cells with epithelial-mesenchymal transition features, " International Journal of Molecular Sciences, vol. 14, no. 8, pp. 15655-15668, 2013.
21. M. Hedayati, N. Shafaghati, and S. J. Hosseinimehr, "Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes, " Radiation and Environmental Biophysics, vol. 52, no. 2, pp. 287-291, 2013.
22. N. Sebastìa, A. Montoro, A. Montoro et al., "Assessment in vitro of radioprotective efcacy of curcumin and resveratrol, " Radiation Measurements, vol. 46, no. 9, pp. 962-966, 2011.
23. C. Chen, X. Jiang, Y. Hu, and Z. Zhang, "The protective role of resveratrol in the sodium arsenite-induced oxidative damage via modulation of intracellular GSH homeostasis, " Biological Trace Element Research, vol. 155, no. 1, pp. 119-131, 2013.
24. G. Ö. Kavas, P. A. Ayral, and A. H. Elhan, "The effects of resveratrol on oxidant/antioxidant systems and their cofactors in rats, " Advances in Clinical and Experimental Medicine, vol. 22, no. 2, pp. 151-155, 2013.
25. M. Singh, K. Bhui, R. Singh, and Y. Shukla, "Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis, " Life Sciences, vol. 93, no. 1, pp. 7-16, 2013.
26. S. A. Ashraf, S. J. Hosseinimehr, K. Varmira, and S. M. Abedi, "Radioimmunotherapy with 131I-bevacizumab as a specifc molecule for cells with overexpression of the vascular endothe-lial growth factor, " Cancer Biotherapy and Radiopharmaceuti-cals, vol. 27, no. 7, pp. 420-425, 2012.
27. Y. Shi, S. Yang, S. Troup et al., "Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1, " Oncology Reports, vol. 25, no. 6, pp. 1713-1719, 2011.
28. A. Shih, F. B. Davis, H.-Y. Lin, and P. J. Davis, "Resveratrol induces apoptosis in thyroid cancer cell lines via a MAPK-and p53-dependent mechanism, " The Journal of Clinical Endocrinology & Metabolism, vol. 87, no. 3, pp. 1223-1232, 2002.
29. X. Zhu, Q. Liu, M. Wang et al., "Activation of Sirt1 by resveratrol inhibits TNF-α induced infammation in fbroblasts, " PloS ONE, vol. 6, no. 11, Article ID e27081, 2011.
30. B. Liu, Z. Zhou, W. Zhou et al., "Resveratrol inhibits proliferation in human colorectal carcinoma cells by inducing G1/Sphase cell cycle arrest and apoptosis through caspase/cyclinCDK pathways, " Molecular Medicine Reports, vol. 10, no. 4, pp. 1697-1702, 2014.
31. C. Zhou, J. Ding, and Y. Wu, "Resveratrol induces apoptosis of bladder cancer cells via miR21 regulation of the Akt/Bcl2 signaling pathway, " Molecular Medicine Reports, vol. 9, no. 4, pp. 1467-1473, 2014.
32. D. Hotnog, M. Mihaila, I. V. Lancu et al., "Resveratrol modulates apoptosis in 5-fuorouracyl treated colon cancer cell lines, " Roumanian Archives of Microbiology and Immunology, vol. 72, no. 4, pp. 255-264, 2013.
33. L. H. Duntas, "Resveratrol and its impact on aging and thyroid function, " Journal of Endocrinological Investigation, vol. 34, no. 10, pp. 788-792, 2011.
34. H. J. Kang, Y.-K. Youn, M.-K. Hong, and L. S. Kim, "Antipro-liferation and rediferentiation in thyroid cancer cell lines by polyphenol phytochemicals, " Journal of Korean Medical Science, vol. 26, no. 7, pp. 893-899, 2011.
35. H.-Y. Lin, H.-Y. Tang, A. Shih et al., "Tyroid hormone is a MAPK-dependent growth factor for thyroid cancer cells and is anti-apoptotic, " Steroids, vol. 72, no. 2, pp. 180-187, 2007.
36. X. M. Yu, R. Jaskula-Sztul, K. Ahmed, A. D. Harrison, M. Kunnimalaiyaan, and H. Chen, "Resveratrol induces difer-entiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth, " Molecular Cancer Terapeutics, vol. 12, no. 7, pp. 1276-1287, 2013.
37. H. Sebai, S. Hovsépian, E. Ristorcelli, E. Aouani, D. Lombardo, and G. Fayet, "Resveratrol increases iodide trapping in the rat thyroid cell line FRTL-5, " Tyroid, vol. 20, no. 2, pp. 195-203, 2010.
38. M. Frombaum, S. le Clanche, D. Bonnefont-Rousselot, and D. Borderie, "Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and NO bioavailability: potential benefts to cardiovascular diseases, " Biochimie, vol. 94, no. 2, pp. 269-276, 2012.
39. C. Iuga, J. R. Alvarez-Idaboy, and N. Russo, "Antioxidant activity of trans-resveratrol toward hydroxyl and hydroperoxyl radicals: a quantum chemical and computational kinetics study, " Journal of Organic Chemistry, vol. 77, no. 8, pp. 3868-3877, 2012.
40. A. Quincozes-Santos, L. D. Bobermin, A. Latini et al., "Resver-atrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1, " PLoS ONE, vol. 8, no. 5, Article ID e64372, 2013.
41. N. Sebastìa, M. Almonacid, J. I. Villaescusa et al., "Radioprotec-tive activity and cytogenetic effect of resveratrol in human lymphocytes: an in vitro evaluation, " Food and Chemical Toxicology, vol. 51, no. 1, pp. 391-395, 2013.
42. Y. Fu, Y. Wang, L. Du et al., "Resveratrol inhibits ionising irradiation-induced infammation in MSCs by activating Sirt1 and limiting NLRP-3 infammasome activation, " International Journal of Molecular Sciences, vol. 14, no. 7, pp. 14105-14118, 2013.